CDK4 and esophageal squamous cell carcinoma: Given that ESCC cell lines show different sensitivities to ART treatment, four ESCC cell lines with different genomic backgrounds of p53 and Cdk4/6-p16-Rb cell cycle checkpoint pathways were utilized for detailed analyses of the effects of ART on ESCC cells.